FDA Schedules Outside Panel Review Of Sanofi Aventis' Antibiotic Ketek Amid Reports Of Liver Failure

You may also like these news :

• Announcing a Blogging and Writing Experiment: Seven Legal Technology Trends for 2007 (A Series of Blog Posts)
• Spanish Language Style Guide and Glossaries for U.S. Government Web Sites
• Presentation on 3 Must-Use Online Tools for Journalists

Following on the heels of reports of liver failure for persons using the Sanofi Aventis antibiotic Ketek, the FDA has convened an independent panel of experts to review the medication's safety. (PRWeb Nov 19, 2006)

Click here for the source

Back